Indolylarylsulfones as HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: New Cyclic Substituents at Indole-2-carboxamide

被引:134
作者
La Regina, Giuseppe [1 ]
Coluccia, Antonio [1 ]
Brancale, Andrea [2 ]
Piscitelli, Francesco [1 ]
Gatti, Valerio [1 ]
Maga, Giovanni [3 ]
Samuele, Alberta [3 ]
Pannecouque, Christophe [5 ]
Schols, Dominique [5 ]
Balzarini, Jan [5 ]
Novellino, Ettore [4 ]
Silvestri, Romano [1 ]
机构
[1] Univ Roma La Sapienza, Inst Pasteur, Fdn Cenci Bolognetti, Dipartimento Chim & Tecnol Farmaco, I-00185 Rome, Italy
[2] Cardiff Univ, Welsh Sch Pharm, Cardiff CF10 3NB, S Glam, Wales
[3] CNR, Ist Genet Mol, I-27100 Pavia, Italy
[4] Univ Naples Federico II, Dipartimento Chim Farmaceut & Tossicol, I-80131 Naples, Italy
[5] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
关键词
INDOLYL ARYL SULFONES; WILD-TYPE; DRUG-RESISTANCE; CRYSTAL-STRUCTURES; BINDING MODE; IN-VITRO; MUTATIONS; DISCOVERY; POTENT; DERIVATIVES;
D O I
10.1021/jm101614j
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
New indolylarylsulfone derivatives bearing cyclic substituents at indole-2-carboxamide linked through a methylene/ethylene spacer were potent inhibitors of the WT HIV-1 replication in CEM and PBMC cells with inhibitory concentrations in the low nanomolar range. Against the mutant L100I and K103N RT HIV-1 strains in MT-4 cells, compounds 20, 24-26, 36, and 40 showed antiviral potency superior to that of NVP and EFV. Against these mutant strains, derivatives 20, 24-26, and 40 were equipotent to ETV. Molecular docking experiments on this novel series of IAS analogues have also suggested that the H-bond interaction between the nitrogen atom in the carboxamide chain of IAS and Glu138:B is important in the binding of these compounds. These results are in accordance with the experimental data obtained on the WT and on the mutant HIV-1 strains tested.
引用
收藏
页码:1587 / 1598
页数:12
相关论文
共 55 条
[1]  
[Anonymous], FLEXX VERS 2 2
[2]  
[Anonymous], AMBERTOOLS VERS 1 4
[3]  
[Anonymous], COD SCOR SVL WAS OBT
[4]  
[Anonymous], 2009 AIDS EPIDEMIC U
[5]  
[Anonymous], PYMOL VERS 1 2R1
[6]  
[Anonymous], MOL OP ENV MOE VERS
[7]   ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].
BARRESINOUSSI, F ;
CHERMANN, JC ;
REY, F ;
NUGEYRE, MT ;
CHAMARET, S ;
GRUEST, J ;
DAUGUET, C ;
AXLERBLIN, C ;
VEZINETBRUN, F ;
ROUZIOUX, C ;
ROZENBAUM, W ;
MONTAGNIER, L .
SCIENCE, 1983, 220 (4599) :868-871
[8]   The Amber biomolecular simulation programs [J].
Case, DA ;
Cheatham, TE ;
Darden, T ;
Gohlke, H ;
Luo, R ;
Merz, KM ;
Onufriev, A ;
Simmerling, C ;
Wang, B ;
Woods, RJ .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2005, 26 (16) :1668-1688
[9]   Characterization and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to nonnucleoside inhibitors [J].
Ceccherini-Silberstein, Francesca ;
Svicher, Valentina ;
Sing, Tobias ;
Artese, Anna ;
Santoro, Maria Mercedes ;
Forbici, Federica ;
Bertoli, Ada ;
Alcaro, Stefano ;
Palamara, Guido ;
Monforte, Antonella d'Arminio ;
Balzarini, Jan ;
Antinori, Andrea ;
Lengauer, Thomas ;
Perno, Carlo Federico .
JOURNAL OF VIROLOGY, 2007, 81 (20) :11507-11519
[10]  
Corbett JW, 2002, PROGR MED CHEM, V40, P63, DOI 10.1016/S0079-6468(08)70082-1